Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544709 · ClinicalTrials.gov registry record · Phase 4
Intradiscal Platelet Rich Plasma
A Phase 4 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04544709 is a Phase 4 study that was terminated before completion, run by University of Utah. The registered enrollment target is 3 participants.
The verdict
NCT04544709, a Phase 4 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).
Interventions
- DRUG Low back intradiscal injection of platelet rich plasma (PRP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2022-07-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04544709
The ClinicalTrials.gov registry entry for NCT04544709 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low back intradiscal injection of platelet rich plasma (PRP) is the first listed.
NCT04544709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04544709 about?
NCT04544709 is a clinical study titled "Intradiscal Platelet Rich Plasma". To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).
What is the current status of trial NCT04544709?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2019-02-14. Estimated completion is 2022-07-29.
What interventions are being tested in trial NCT04544709?
The interventions under investigation include: Low back intradiscal injection of platelet rich plasma (PRP) (DRUG).
Who is sponsoring clinical trial NCT04544709?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.